$HIPH- News out! Today's PR! #CBD product for pets in

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
515
$HIPH- News out! Today's PR! #CBD product for pets in works, cutting costs & new deal that streamlines production.


American Premium Water Corp. Ramps Production and Reduces CostsPress Release | 04/12/2018

PLAYA VISTA, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that they have entered into a long-term supply agreement with a US-based hydrogen beverage supplier enabling the company to increase and streamline production while reducing cost.

This agreement gives the Company a manufacturing partner that has the capability to scale. The first order for LALPINA Hydrogen has already been placed and the product will be available for sale across all channels in the next few weeks.

Ryan Fishoff, CEO American Premium Water Corporation, commented: “This supply agreement is a pinnacle step in establishing LALPINA as the market leader in hydrogen energy products. This agreement not only provides us with a stable supply, but it also allows us to manufacture LALPINA Hydrogen domestically, which will significantly reduce shipping costs. It will also significantly reduce lead times, which will allow us to better utilize capital and not have it tied up with in-transit inventory.”

Previously, HIPH was sourcing its LALPINA Hydrogen from Japan. The Company will still continue its relationship with this supplier as it eyes expansion into Asia, leveraging HIPH’s Gents subsidiary’s joint-venture in China as a platform for Asian expansion.

“In addition to no longer having to ship the product over the Pacific, our new supplier is producing LALPINA in metal cans, which will increase the shelf life of the product by 100%. (90 to 180 days). This will greatly expand the pool of retailers who can now carry our product, expanding our potential reach, maximizing our ability to capture market share and drive revenue growth. The supplier can also produce CBD infused hydrogen and other hydrogen infused products that we are excited about and will be announcing as they become available,” added Mr. Fishoff.

HIPH is still on schedule to release LALPINA Hydrogen CBD by the end of June or sooner. The Company has started initial R&D with its new supplier on developing a hydrogen CBD beverage formulated specifically for the pets. The pet market is currently estimated to be a $26 Billion industry according to the market research firm Packaged Facts.

“The pet food industry is huge. Being a pet owner myself, I know what pet owners will do (and spend) for their pets. I recently learned that Chrissy Teigen tried CBD to ease her bulldog’s pain, and I think hydrogen can be an effective CBD delivery system for pets as well. If my bulldog had the same issues, I would do and spend whatever I had to alleviate its pain. I look forward to working with our new supplier to develop this among products for many other applications. I also want to explore doing a THC/Cannabis beverage for the states where it is legal. These are all products that we can offer to establish LALPINA as the preeminent hydrogen infused brand,” Mr. Fishoff concluded.

American Premium Water Corp is the publicly holding trading company that owns LALPINA HYDROGEN, LALPINA HYDROGEN CBD & Gents.

Please follow us on our social media outlets listed below:

@americanpremium

@lalpinabrands

@GentsCo

#Gentsco

#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s, Nordstrom, and Saks Fifth Avenue.

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading